COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1417: Articles 14161-14170  | Next

Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine
Larsen, V. B., Grosland, M., Telle, K. E., Magnusson, K.
10.1101/2021.07.09.21260250 — Posted: 2021-07-13
Heterologous immunisation with vector vaccine as prime followed by mRNA vaccine as boost leads to humoral immune response against SARS-CoV-2, which is comparable to that according to a homologous mRNA vaccination scheme
Rose, R., Neumann, F., Grobe, O., Lorentz, T., Fickenscher, H., Krumbholz, A.
10.1101/2021.07.09.21260251 — Posted: 2021-07-13
Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19
Banday, A. R., Stanifer, M. L., Florez-Vargas, O., Onabajo, O. O., Zahoor, M. A., Papenberg, B. W., Ring, T. J., Lee, C.-H., Andreakos, E., Arons, E., Barsh, G., Biesecker, L. G., Boyle, D. L., Burnett-Hartman, A., Carrington, M., Chang, E., Choe, P. G., Chrisholm, R. L., Dalgard, C., Edberg, J., Erdmann, N., Feigelson, H. S., Firestein, G. S., Gehring, A. J., Ho, M., Holland, S., Hutchinson, A. A., Im, H., Ison, M. G., Kim, H. B., Kreitman, R. J., Korf, B. R., Mirabello, L., Pacheco, J. A., Peluso, M. J., Rader, D. J., Redden, D. T., Ritchie, M. D., Rosenbloom, B., Sant Anna, H. P., Savage, S., Siouti, E., Triantafyllia, V., Vargas, J. M., Verma, A., Vij, V., Wesemann, D. R., Yeager, M., Yu, X., Zhang, Y., Boulant, S., Chanock, S. J., Feld, J. J., Prokunina-Olsson, L.
10.1101/2021.07.09.21260221 — Posted: 2021-07-13
COVID-19 vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination among primary school teachers in Poland
Malesza, M., Sobolewska, K.
10.1101/2021.07.11.21260317 — Posted: 2021-07-13
Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview
Axfors, C., Ioannidis, J. P. A.
10.1101/2021.07.08.21260210 — Posted: 2021-07-13 Discussion: Onsite | Offsite
Humoral immune response in inactivated SARS-CoV-2 vaccine: When should a booster dose be administered?
Kara, E., Tanir, F., Demirhindi, H., Mete, B., Kibar, F., Cetiner, S., Candevir, A., Inaltekin, A.
10.1101/2021.07.08.21260194 — Posted: 2021-07-13
Drug-free nasal spray as a barrier against SARS-CoV-2 infection: safety and efficacy in human nasal airway epithelia
Fais, F., Juskeviciene, R., Francardo, V., Mateos, S., Constant, S., Borelli, M., Hohenfeld, I. P., Meyer, T.
10.1101/2021.07.12.452021 — Posted: 2021-07-12
Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model
O'Donnell, K. L., Pinski, A. N., Clancy, C. S., Gourdine, T., Shifflett, K., Fletcher, P., Messaoudi, I., Marzi, A.
10.1101/2021.07.11.451964 — Posted: 2021-07-12
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ke, R., Martinez, P. P., Smith, R. L., Gibson, L. L., Mirza, A., Conte, M., Gallagher, N., Luo, C. H., Jarrett, J., Conte, A., Liu, T., Farjo, M., Walden, K. K. O., Rendon, G., Fields, C. J., Wang, L., Fredrickson, R., Edmonson, D. C., Baughman, M. E., Chiu, K. K., Choi, H., Scardina, K. R., Bradley, S., Gloss, S. L., Reinhart, C., Yedetore, J., Quicksall, J., Owens, A. N., Broach, J., Barton, B., Lazar, P., Heetderks, W., Robinson, M. L., Mostafa, H. H., Manabe, Y. C., Pekosz, A., McManus, D. D., Brooke, C. B.
10.1101/2021.07.12.21260208 — Posted: 2021-07-12
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: a Computational Model of Epitope Loss in Variants of Concern
Triveri, A., Serapian, S. A., Marchetti, F., Doria, F., Pavoni, S., Cinquini, F., Moroni, E., Rasola, A., Frigerio, F., Colombo, G.
10.1101/2021.07.12.452002 — Posted: 2021-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).